Status:
COMPLETED
The Vietnam Chloroquine Treatment on COVID-19
Lead Sponsor:
Oxford University Clinical Research Unit, Vietnam
Collaborating Sponsors:
Ministry of Health, Vietnam
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
Conditions:
SARS-CoV-2 Infection
COVID-19
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There is currently no vaccine to prevent COVID-19 or therapeutic agent to t...
Detailed Description
The study will start with a 10-patient prospective observational pilot study. All these patients will be subject to the same entry and exclusion criteria for the randomized trial, and undergo the same...
Eligibility Criteria
Inclusion
- Laboratory-confirmed SARS-CoV-2 infection as determined by PCR, or other commercial or public health assay in any specimen \< 48 hours prior to randomization, and requiring hospital admission in the opinion of the attending physician.
- Provides written informed consent prior to initiation of any study procedures (or legally authorized representative).
- Understands and agrees to comply with planned study procedures.
- Agrees to the collection of OP swabs and venous blood per protocol.
- Male or female adult ≥18 years of age at time of enrollment.
Exclusion
Key Trial Info
Start Date :
April 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04328493
Start Date
April 7 2020
End Date
September 10 2020
Last Update
May 24 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
National Hospital for Tropical Diseases
Hanoi, Vietnam
2
Can Gio COVID Hospital
Ho Chi Minh City, Vietnam
3
Cho Ray Hospital
Ho Chi Minh City, Vietnam
4
Cu Chi COVID Hospital
Ho Chi Minh City, Vietnam